作者: Luke H Hoeppner , Ying Wang , Anil Sharma , Naureen Javeed , Virginia P Van Keulen
DOI: 10.1016/J.MOLONC.2014.08.008
关键词: Immunology 、 Vascular endothelial growth factor A 、 Angiogenesis 、 Epidermal growth factor receptor 、 Cancer research 、 Lung 、 Lung cancer 、 Agonist 、 Endothelium 、 Biology 、 Myeloid-derived Suppressor Cell
摘要: We sought to determine whether Dopamine D2 Receptor (D2R) agonists inhibit lung tumor progression and identify subpopulations of cancer patients that benefit most from D2R agonist therapy. demonstrate abrogate in syngeneic (LLC1) human xenograft (A549) orthotopic murine models through inhibition angiogenesis reduction infiltrating myeloid derived suppressor cells. Pathological examination tissue revealed a positive correlation between endothelial expression stage. Lung with smoking history exhibited greater levels endothelium. Our results suggest may represent promising individualized therapy for high history.